Spanish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

inflammation/diarrea

El enlace se guarda en el portapapeles.
Página 1 desde 92 resultados

Materials and methods for prevention and treatment of diarrhea and inflammation in the gastrointestinal tract

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF INVENTION Diarrhea is a common illness affecting people of all ages. The loss of fluids through diarrhea can cause dehydration and electrolyte disturbances. In the United Sates, adults have an average of one episode of acute diarrhea each year; diarrhea occurs more frequently in

Composition and method for reducing diarrhea in a mammal

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION Maintaining the well being of the GI tract of a mammal is a very desirable goal. Particularly annoying are inflammatory conditions of the GI tract. Some of the signs of inflammation of the GI tract include acute or chronic diarrhea, soft stools, blood in stool, vomiting,

Amorphous (quinolin-2-ylmethoxy)indole compounds useful for treating inflammatory diseases

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION EP 419,049, Prasit et al., Mar. 27, 1991, describes a series of quinolin-2-ylmethoxy indoles useful as inhibitors of leukotriene biosynthesis. Examples 1 and 1A therein teach the synthesis of 3-[N-(p-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-ylmethoxy)indol-2-yl]-

5-ASA derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION The present invention relates to 5-ASA derivatives and methods of treating diseases therewith. BACKGROUND OF THE INVENTION Many people suffer from inflammatory bowel disease (IBD). TRD is a generic term used to refer to two inflammatory diseases, ulcerative colitis and Crohn's

Compounds as rearranged during transfection (RET) inhibitors

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF INVENTION This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of

Pyridone derivatives as rearranged during transfection (RET) kinase inhibitors

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
This application is a .sctn. 371 of International Application No. PCT/IB2015/056905, filed 9 Sep. 2015, which claims the priority of PCT/CN2015/086995, filed 14 Aug. 2015, and PCT/CN2014/086197, filed 10 Sep. 2014, which are incorporated herein in their entireties. FIELD OF INVENTION This invention

Compounds as rearranged during transfection (RET) inhibitors

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF INVENTION This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of

Compounds as rearranged during transfection (RET) inhibitors

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF INVENTION This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of

Compounds as rearranged during transfection (RET) inhibitors

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF INVENTION This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of

Compounds as rearranged during transfection (RET) inhibitors

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF INVENTION This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of

Compounds as rearranged during transfection (RET) inhibitors

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
This application is a .sctn.371 of International Application No. PCT/CN2015/089332, filed 10 Sep. 2015, which claims the priority of PCT/CN2014/000834, filed 10 Sep. 2014, which are incorporated herein in their entireties. FIELD OF INVENTION This invention relates to novel compounds which are

Compounds as rearranged during transfection (RET) inhibitors

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF INVENTION This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of

Compounds as rearranged during transfection (RET) inhibitors

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF INVENTION This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of

Pyridine derivatives as rearranged during transfection (RET) kinase inhibitors

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
This application is a 371 of International Application No. PCT/IB2014/059817, filed 14 Mar. 2014, which claims priority of PCT/CN2014/072449, filed 24 Feb. 2014; PCT/CN2013/090059, filed 20 Dec. 2013; and PCT/CN2013/072683, filed 15 Mar. 2013. FIELD OF INVENTION This invention relates to novel

Vanilloid receptor ligands and their use in treatments

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND The vanilloid receptor 1 (VR1) is the molecular target of capsaicin, the active ingredient in hot peppers. Julius et al. reported the molecular cloning of VR1 (Caterina et al., 1997). VR1 is a non-selective cation channel which is activated or sensitized by a series of different stimuli
Únete a nuestra
página de facebook

La base de datos de hierbas medicinales más completa respaldada por la ciencia

  • Funciona en 55 idiomas
  • Curas a base de hierbas respaldadas por la ciencia
  • Reconocimiento de hierbas por imagen
  • Mapa GPS interactivo: etiquete hierbas en la ubicación (próximamente)
  • Leer publicaciones científicas relacionadas con su búsqueda
  • Buscar hierbas medicinales por sus efectos.
  • Organice sus intereses y manténgase al día con las noticias de investigación, ensayos clínicos y patentes.

Escriba un síntoma o una enfermedad y lea acerca de las hierbas que podrían ayudar, escriba una hierba y vea las enfermedades y los síntomas contra los que se usa.
* Toda la información se basa en investigaciones científicas publicadas.

Google Play badgeApp Store badge